Yangzhe Wu

Zhuhai, 519099, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Intraperitoneal OK-432 infusion for postoperative lymphatic leakage in gynecologic tumors.

Intraperitoneal OK-432 infusion for postoperative lymphatic leakage in gynecologic tumors.

Journal: Gynecologic oncology reports

Published: July 14, 2026

Gut Microbiota, Immunity, and Metabolism in the Progression From Chronic Liver Disease to Hepatocellular Carcinoma.

Gut Microbiota, Immunity, and Metabolism in the Progression From Chronic Liver Disease to Hepatocellular Carcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 19, 2025

RCC1 knockdown sensitizes drug-resistant colorectal cancer to 5-fluorouracil or doxorubicin by impairing DNA repair.

RCC1 knockdown sensitizes drug-resistant colorectal cancer to 5-fluorouracil or doxorubicin by impairing DNA repair.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: August 05, 2025

Remodelling hypoxic TNBC microenvironment restores antitumor efficacy of Vγ9Vδ2 T cell therapy.

Remodelling hypoxic TNBC microenvironment restores antitumor efficacy of Vγ9Vδ2 T cell therapy.

Journal: British journal of cancer

Published: January 03, 2025

Hyperglycemic milieu impairs Vγ9Vδ2 T cell functions in tuberculosis patients and prolongs M.tb negative conversion time.

Hyperglycemic milieu impairs Vγ9Vδ2 T cell functions in tuberculosis patients and prolongs M.tb negative conversion time.

Journal: iScience

Published: August 25, 2024

Harnessing CD8+ T cell dynamics in hepatitis B virus-associated liver diseases: Insights, therapies and future directions.

Harnessing CD8+ T cell dynamics in hepatitis B virus-associated liver diseases: Insights, therapies and future directions.

Journal: Clinical and translational medicine

Published: February 05, 2024

γδ T cells: origin and fate, subsets, diseases and immunotherapy.

γδ T cells: origin and fate, subsets, diseases and immunotherapy.

Journal: Signal transduction and targeted therapy

Published: June 30, 2023

Programmed Cell Death Tunes Tumor Immunity.

Programmed Cell Death Tunes Tumor Immunity.

Journal: Frontiers in immunology

Published: January 02, 2022

Apoptosis, Pyroptosis, and Ferroptosis Conspiringly Induce Immunosuppressive Hepatocellular Carcinoma Microenvironment and γδ T-Cell Imbalance.

Apoptosis, Pyroptosis, and Ferroptosis Conspiringly Induce Immunosuppressive Hepatocellular Carcinoma Microenvironment and γδ T-Cell Imbalance.

Journal: Frontiers in immunology

Published: December 30, 2021

Hepatocellular carcinoma-infiltrating γδ T cells are functionally defected and allogenic Vδ2+ γδ T cell can be a promising complement.

Hepatocellular carcinoma-infiltrating γδ T cells are functionally defected and allogenic Vδ2+ γδ T cell can be a promising complement.

Journal: Clinical and translational medicine

Published: December 13, 2021

Transient 40 °C-shock potentiates cytotoxic responses of Vδ2+ γδ T cell via HSP70 upregulation.

Transient 40 °C-shock potentiates cytotoxic responses of Vδ2+ γδ T cell via HSP70 upregulation.

Journal: Cancer immunology, immunotherapy : CII

Published: August 29, 2021

Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis.

Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis.

Journal: Frontiers in immunology

Published: August 10, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026